Crossmark

Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review

Crossref DOI link: https://doi.org/10.1007/s00520-026-10690-2

Published Online: 2026-05-07

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alberti, Paola

Faithfull, Sara

Argyriou, Andreas A.

Balayssac, David

Hertz, Daniel L.

Lustberg, Maryam

Park, Susanna B.

Li, Tiffany

Tanay, Mary

Jabaley, Terri

Worthen-Chaudhari, Lise

Smith, Ellen M. L.

,
License Information

Text and Data Mining valid from 2026-05-07

Version of Record valid from 2026-05-07
More Information

Article History

Received: 4 January 2026

Accepted: 15 April 2026

First Online: 7 May 2026

Declarations

:

: This is a consensus document developed with permission of the workshop participants with consent for publication prior to attending and therefore ethical approval is not required.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below